PSKY heads into September carrying a sharp contradiction: the stock has rallied 33% in a month, yet the Street's unanimous verdict is sell, and short sellers are only slowly backing away.
The positioning picture is more nuanced than the bearish headline suggests. Short interest has eased — down roughly 9% over the past month to around 77.4 million shares — but that unwinding has been gradual and steady, not a conviction reversal. Borrow costs remain low at 1.31%, well off the 3.1% peak seen in late July. Availability is in the tight-to-normal band at 110%, meaning there are roughly 1.1 shares available for every share already borrowed — not a stressed lending market, but not a loose one either. The ORTEX short score holds at 74.4, near the top of its recent range, flagging that the overall short setup remains elevated even as individual metrics ease. Options traders, meanwhile, are marginally less defensive than usual: the put/call ratio is 0.93, slightly below its 20-day average of 0.94, with a z-score of -0.68 — a quiet, unremarkable read that suggests no surge in hedging demand despite the recent volatility.
The analyst community is notably bearish, and the gap between their targets and the current price is the week's most interesting tension. The consensus is a sell, with six analysts at that rating and a mean price target of $9.69 — an implied . UBS cut its target to $8 in early August while holding its Sell, and TD Cowen trimmed to $8 from $13 on the same day. The sole outlier is Benchmark, which kept a Buy but reduced its target to $16 from $19. The pattern is consistent: even constructive voices are trimming expectations. Valuation multiples have re-rated upward with the stock's one-month rally — the price-to-book has climbed meaningfully over 30 days and the trailing PE now reads 14.4x — but the EV/EBITDA at 6.5x suggests the market is not pricing in a premium recovery. Factor scores reinforce the skepticism: the analyst recommendation rank sits at just the 8th percentile, and the EPS surprise rank at 23 signals the company has not been a consistent earnings beater.
The ownership structure is worth noting because it is unusual. David Ellison holds 30% of shares outstanding — a controlling position that severely constrains what short sellers can borrow and what the float actually represents. Redbird Capital Partners holds another 9.3%, and Skydance Entertainment Group holds 6.8%. Combined, these strategic holders account for nearly half the company's shares, which goes some way to explaining why short interest as a percentage of the free float — the relevant denominator — is difficult to pin down precisely from the data available. Among the smaller institutional holders, Pentwater Capital Management added 7.9 million shares in the quarter ending June 30, a notable addition from a fund known for event-driven and merger-arb strategies.
The earnings history adds context to the stock's moves. The most recent print in early August produced a 6.6% one-day gain and extended to a 14.1% five-day move — a meaningful positive surprise reaction. The prior quarter saw a similar pattern: +5.3% on the day, +16.5% over the following week. The next event is on November 4. The bull case rests on sports-driven retransmission growth, new leadership at the content level, and direct-to-consumer momentum. The bear case is more structural: revenues have fallen 41% since 2021, linear TV consumption is declining, and advertising cycles add volatility that the company has limited ability to manage around.
Correlated peers have had a rough week. AMCX fell 3.8%, SBGI dropped 5.7%, and GTN slid 5.6% — all underperforming PSKY's 1.1% weekly decline. Whether that relative resilience reflects genuine differentiation or simply mean-reversion fatigue after a 33% monthly surge is the question to watch heading into the next earnings cycle.
See the live data behind this article on ORTEX.
Open PSKY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
